Safety and Immunogenicity of EV71 Vaccine With or Without Aluminum Adjuvant in Infants
Phase 2
Withdrawn
- Conditions
- Infection, Viral, Enterovirus
- Interventions
- Biological: 400 U EV71 vaccine with adjuvant
- First Posted Date
- 2013-03-15
- Last Posted Date
- 2021-07-29
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Registration Number
- NCT01812135
- Locations
- 🇨🇳
GuangXi Center for Diseases Control and Prevention, Nanning, Guangxi, China
The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine
Phase 4
Completed
- Conditions
- Influenza
- Interventions
- Biological: 2012-2013 trivalent seasonal influenza vaccine
- First Posted Date
- 2012-11-29
- Last Posted Date
- 2013-05-29
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 202
- Registration Number
- NCT01736709
- Locations
- 🇨🇳
Henan Center for Diseases Control and Prevention, Zhengzhou, Henan, China
Immunogenicity and Safety of Three Consecutive Lots of a New Inactivated Enterovirus Type 71 (EV71) Vaccine
Phase 3
Completed
- Conditions
- Hand, Foot and Mouth Disease
- Interventions
- Biological: three consecutive lots of EV71 vaccineBiological: placebo
- First Posted Date
- 2012-07-10
- Last Posted Date
- 2013-03-15
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 1400
- Registration Number
- NCT01636245
- Locations
- 🇨🇳
Jurong, ZhenJiang, Jiangsu, China
An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine
Phase 3
Completed
- Conditions
- Hand, Foot and Mouth Disease
- Interventions
- Biological: 400U /0.5ml EV71 vaccineBiological: 0/0.5ml placebo
- First Posted Date
- 2012-01-11
- Last Posted Date
- 2013-11-28
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 10077
- Registration Number
- NCT01507857
- Locations
- 🇨🇳
Taixing, Taizhou, Jiangsu, China
🇨🇳Sheyang CDC, Yancheng, Jiangsu, China
🇨🇳Ganyu, Lianyungang, Jiangsu, China
Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants
Phase 2
Completed
- Conditions
- Infection, Viral, Enterovirus
- Interventions
- Biological: 100U EV71 vaccine with adjuvantBiological: 200 U EV71 vaccine with adjuvantBiological: 400U EV71 vaccine with adjuvantBiological: 200U EV71 vaccine without adjuvantBiological: Placebo
- First Posted Date
- 2011-08-22
- Last Posted Date
- 2012-11-27
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 540
- Registration Number
- NCT01421121
- Locations
- 🇨🇳
GuangXi Center for Diseases Control and Prevention, Nanning, Guangxi, China
Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy Children
Phase 1
Completed
- Conditions
- Hand-foot-mouth DiseaseInfection; Viral, Enterovirus
- Interventions
- Biological: 200U inactivated Enterovirus Type 71 VaccineBiological: PlaceboBiological: 400U inactivated Enterovirus Type 71 VaccineBiological: 100U inactivated Enterovirus Type 71 Vaccine
- First Posted Date
- 2011-01-10
- Last Posted Date
- 2021-07-28
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 132
- Registration Number
- NCT01273246
- Locations
- 🇨🇳
GuangXi Center for Diseases Control and Prevention, Nanning, Guangxi, China
Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy Adults
Phase 1
Completed
- Conditions
- Infection; Viral, Enterovirus
- Interventions
- Biological: Inactivated Enterovirus Type 71 VaccineOther: Placebo
- First Posted Date
- 2011-01-10
- Last Posted Date
- 2013-03-15
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT01273233
- Locations
- 🇨🇳
GuangXi Center for Diseases Control and Prevention, Nanning, Guangxi, China
Immunogenicity and Interchangeability of Two Inactivated Hepatitis A Vaccines
Phase 4
Completed
- Conditions
- Hepatitis A
- Interventions
- Biological: Healive+HealiveBiological: Healive+HavrixBiological: Havrix+HavrixBiological: Havrix+Healive
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2013-03-15
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 303
- Registration Number
- NCT01252680
- Locations
- 🇨🇳
Tianjin Centers for Diseases Control and Prevention, Tianjin, Tianjin, China
Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants
Phase 4
Completed
- Conditions
- Influenza
- Interventions
- Biological: Pandemic influenza A/H1N1 vaccineBiological: Seasonal trivalent vaccine
- First Posted Date
- 2010-01-12
- Last Posted Date
- 2013-03-15
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 310
- Registration Number
- NCT01047202
- Locations
- 🇨🇳
GuangXi Center for Diseases Control and Prevention, Guilin, Guangxi, China
Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, Adults
Phase 4
Completed
- Conditions
- Influenza
- Interventions
- Biological: H1N1 influenza A Vaccine (PANFLU.1)Biological: Trivalent Inactivated Influenza Vaccine (ANFLU)
- First Posted Date
- 2009-11-05
- Last Posted Date
- 2012-11-27
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 150
- Registration Number
- NCT01008137
- Locations
- 🇨🇳
Beijing Centers for Diseases Control and Prevention, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath